|
|
|
|
|
by maxerickson
1965 days ago
|
|
Lots of reason for optimism. The vaccines can be retargeted, and like the flu vaccine, approved with a faster trial. And the mRNA vaccine production can continue to scale up. So if there is a need for a new vaccine, we can likely deploy it with a shorter interval to availability and much larger initial volume. We can also become more disciplined. We don't need to go all the way to a strictly enforced lock down to improve on the social distancing that we've done the last year (at least, not in the US). And we can try to get people to more widely accept contact tracing/tracking. |
|